INFAI is specialized in the transfer of advanced analytical technology in the field of medical diagnostics and the development of innovative pharmaceutical products. The company is a pioneer in the use of stable isotopes and NMR in gastroenterology, oncology and metabolic diseases. INFAI's laboratories in Cologne, Germany are equipped with state-of-the-art NMR and NMR imaging instruments. These facilities are used for internal research and product development, but are also available for collaborative and contract research.
In recent years, a range of non-invasive, highly efficient breath tests using stable isotopes has been developed. One of these tests is already approved and available for routine diagnosis of Helicobacter pylori infections. Other tests used to determine gastric emptying rate and pancreatic insufficiency will be available soon.
NMR spectroscopy and NMR imaging are used by INFAI to investigate metabolic disorders and a number of other diseases. The non-invasive characteristics of these techniques make them particularly interesting for pediatric applications.
INFAI is associated with a number of companies in several European countries.